Zuckerberg San Francisco General Hospital — San Francisco, California

Zuckerberg San Francisco General Hospital is a clinical research site located in San Francisco, California, United States 94110.

Crixeo Clinical Trials Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

Zuckerberg San Francisco General Hospital has participated in 99 clinical trials with 47 currently active.

Therapeutic areas: Estrogen Receptor Positive, HER2 Positive Breast Carcinoma, HER2/Neu Negative.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, Gynecologic Oncology Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in San Francisco

Browse all research sites in California · View every site in San Francisco

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Zuckerberg San Francisco General Hospital?

Zuckerberg San Francisco General Hospital has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Zuckerberg San Francisco General Hospital conducted?

Zuckerberg San Francisco General Hospital has 99 clinical trials on record, with 47 currently active. Their work covers Estrogen Receptor Positive, HER2 Positive Breast Carcinoma, HER2/Neu Negative.

Is Zuckerberg San Francisco General Hospital accredited by Crixeo Clinical Trials?

Zuckerberg San Francisco General Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Zuckerberg San Francisco General Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.